Application of gene transfer technologies to the production of enzyme reference materials: example of gamma-glutamyltransferase.

Protein reference materials are traditionally prepared by purification from mammalian or human tissues. The supply of these tissues is limited; consequently, there is a growing need for applied molecular and cellular biology technologies for the production of human recombinant proteins. This is especially true when only small amounts of the proteins are available in the tissues. We review the current knowledge necessary for high-level production of such proteins in different heterologous expression systems, using our data on gamma-glutamyltransferase (EC 2.3.2.2) as an example. We describe the steps required to achieve the expression of enzymes and other proteins in Escherichia coli, yeast, or mammalian cells. We list many of the problems investigators may face in preparing recombinant proteins, and provide information on selecting the most appropriate system as well as the most favorable experimental conditions. Depending on the expression system, recombinant proteins can potentially be obtained for most, if not all, enzymes of interest in clinical chemistry, and such proteins should possess characteristics very similar to those of the corresponding human native proteins. Studies suggest that these products can be used as reference materials in clinical chemistry laboratories.

[1]  H. Bergmeyer.  Methods of Enzymatic Analysis , 2019 .

[2]  G. Siest,et al.  Interlaboratory study of the IFCC method for alanine aminotransferase performed with use of a partly purified reference material. , 1992, Clinical chemistry.

[3]  H. A. Wood,et al.  Baculovirus Expression of Alkaline Phosphatase as a Reporter Gene for Evaluation of Production, Glycosylation and Secretion , 1992, Bio/Technology.

[4]  J. Shabanowitz,et al.  Sequencing, cloning, and expression of human red cell-type acid phosphatase, a cytoplasmic phosphotyrosyl protein phosphatase. , 1992, The Journal of biological chemistry.

[5]  T. Hada,et al.  Enzymatic basis of sugar structures of α‐fetoprotein in hepatoma and hepatoblastoma cell lines: Correlation with activities of α1–6 fucosyltransferase and N‐acetylglucosaminyltransferases III and V , 1992, International journal of cancer.

[6]  J. Francis,et al.  A Reference Preparation of Human Prostatic Acid Phosphatase: Purification, Characterization and Field Trials , 1992, Annals of clinical biochemistry.

[7]  J R Blackwell,et al.  A novel strategy for production of a highly expressed recombinant protein in an active form , 1991, FEBS letters.

[8]  S. Boddupalli,et al.  Expression, purification, and properties of the flavoprotein domain of cytochrome P-450BM-3. Evidence for the importance of the amino-terminal region for FMN binding. , 1991, The Journal of biological chemistry.

[9]  T. Watanabe,et al.  Mutation of a single amino acid converts germ cell alkaline phosphatase to placental alkaline phosphatase. , 1991, The Journal of biological chemistry.

[10]  G. Siest,et al.  High-level expression of enzymatically active mature human gamma-glutamyltransferase in transgenic V79 Chinese hamster cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[11]  H. Barnes,et al.  Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Sampson,et al.  International Federation of Clinical Chemistry, Scientific Division Committee on Enzymes: approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 7. IFCC method for creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2). , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[13]  L. Post,et al.  Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression. , 1991, Journal of biotechnology.

[14]  G. Siest,et al.  Certification of an enzyme reference material for alkaline phosphatase (CRM 371). , 1991, Clinical biochemistry.

[15]  T. Kadesch,et al.  Post-transcriptional regulation of the human liver/bone/kidney alkaline phosphatase gene. , 1991, The Journal of biological chemistry.

[16]  J. Dixon,et al.  Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. , 1991, Analytical biochemistry.

[17]  G. Siest,et al.  Gamma-glutamyltransferase from human hepatoma cell lines: purification and cell culture of HepG2 on microcarriers. , 1990, Clinica chimica acta; international journal of clinical chemistry.

[18]  W. Chia,et al.  Expression of the copy DNA for human A4 and B4 L-lactate dehydrogenases in Escherichia coli. , 1990, Biochimica et biophysica acta.

[19]  G. Stephanopoulos,et al.  Use of regulated secretion in protein production from animal cells: An evaluation with the AtT‐20 model cell line , 1990, Biotechnology and bioengineering.

[20]  K. Brindle,et al.  31P NMR measurements of the ADP concentration in yeast cells genetically modified to express creatine kinase. , 1990, Biochemistry.

[21]  B. Hammock,et al.  Expression and effects of the juvenile hormone esterase in a baculovirus vector , 1990, Nature.

[22]  S. Boddupalli,et al.  Fatty acid monooxygenation by cytochrome P-450BM-3. , 1990, The Journal of biological chemistry.

[23]  M. Lowe,et al.  Molecular cloning and expression of a cDNA encoding the membrane-associated rat intestinal alkaline phosphatase. , 1990, Biochimica et biophysica acta.

[24]  C. Lazdunski,et al.  The maximum rate of gene expression is dependent on the downstream context of unfavourable codons. , 1989, Biochimie.

[25]  P. Dessen,et al.  Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B Hammarberg,et al.  Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Siest,et al.  Expression of rat renal gamma-glutamyltransferase cDNA in Escherichia coli. , 1989, Biochemical and biophysical research communications.

[28]  P. Christen,et al.  Structure of cDNA of cytosolic aspartate aminotransferase of chicken and its expression in E. coli. , 1989, Biochimie.

[29]  H. Pitot,et al.  Human γ-glutamyl transpeptidase cDNA: comparison of hepatoma and kidney mRNA in the human and rat , 1989 .

[30]  L. Randall,et al.  Unity in function in the absence of consensus in sequence: role of leader peptides in export. , 1989, Science.

[31]  H. Kagamiyama,et al.  cDNA cloning and expression of pig cytosolic aspartate aminotransferase in Escherichia coli: amino-terminal heterogeneity of expressed products and lack of its correlation with enzyme function. , 1989, Biochemistry.

[32]  N. Mackman,et al.  A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium , 1989, Journal of Cell Science.

[33]  C. Kotts,et al.  Expression of secreted insulin-like growth factor-1 in Escherichia coli. , 1988, Gene.

[34]  A. Cigan,et al.  Mutational analysis of the HIS4 translational initiator region in Saccharomyces cerevisiae , 1988, Molecular and cellular biology.

[35]  T. Tanaka,et al.  Rat cytosolic aspartate aminotransferase: molecular cloning of cDNA and expression in Escherichia coli. , 1988, Journal of biochemistry.

[36]  D. Morrison,et al.  Construction and properties of a new insertion vector, pJDC9, that is protected by transcriptional terminators and useful for cloning of DNA from Streptococcus pneumoniae. , 1988, Gene.

[37]  M. Bulmer,et al.  Selective differences among translation termination codons. , 1988, Gene.

[38]  H. Yamashita,et al.  Proteose peptone enhances production of tissue-type plasminogen activator from human diploid fibroblasts. , 1988, Biochemical and biophysical research communications.

[39]  J. Gordon,et al.  Molecular cloning and in vivo expression of a precursor to rat mitochondrial aspartate aminotransferase. , 1987, Biochemical and biophysical research communications.

[40]  P. Board,et al.  Expression of human glutathione S-transferase 2 in Escherichia coli. Immunological comparison with the basic glutathione S-transferases isoenzymes from human liver. , 1987, The Biochemical journal.

[41]  R A Bradshaw,et al.  Specificity of cotranslational amino-terminal processing of proteins in yeast. , 1987, Biochemistry.

[42]  M. Johnston.  A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. , 1987, Microbiological reviews.

[43]  G. Siest,et al.  Production and certification of an enzyme reference material for gamma-glutamyltransferase (CRM 319). Part 1: Preparation and characterization. , 1987, Clinical chemistry.

[44]  G. Siest,et al.  Production and certification of an enzyme reference material for gamma-glutamyltransferase (CRM 319). Part 2: Certification campaign. , 1987, Clinical chemistry.

[45]  J. Pagés,et al.  Production and purification of human growth-hormone-releasing factor from continuous cultures of recombinant-plasmid-containing Escherichia coli. , 1987, European journal of biochemistry.

[46]  P. Christen,et al.  Expression of cDNAs encoding the precursor and the mature form of chicken mitochondrial aspartate aminotransferase in Escherichia coli. , 1987, Journal of Biological Chemistry.

[47]  S. Tate,et al.  A human hepatoma cell line expresses a single-chain form of gamma-glutamyl transpeptidase. , 1987, The Journal of biological chemistry.

[48]  G Pohl,et al.  Expression of human insulin-like growth factor I in bacteria: use of optimized gene fusion vectors to facilitate protein purification. , 1987, Biochemistry.

[49]  A. Ben-Bassat,et al.  Amino-terminal processing of proteins , 1987, Nature.

[50]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[51]  P. H. Van Knippenberg,et al.  Secondary structure as primary determinant of the efficiency of ribosomal binding sites in Escherichia coli , 1986, Nucleic Acids Res..

[52]  M. Hørder,et al.  International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, , 1986 .

[53]  J. Birch,et al.  Large-scale cell culture in biotechnology. , 1986, Science.

[54]  J. B. Faria,et al.  Stable Yeast Transformants that Secrete Functional α–Amylase Encoded by Cloned Mouse Pancreatic cDNA , 1986, Bio/Technology.

[55]  G. Siest,et al.  Reference materials for clinical enzymology: the work of the Community Bureau of Reference of the European Community. , 1986, Annals of clinical biochemistry.

[56]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[57]  M. Holland,et al.  Differential expression of the three yeast glyceraldehyde-3-phosphate dehydrogenase genes. , 1985, The Journal of biological chemistry.

[58]  S. Gottesman,et al.  Insertional mutagenesis of the lon gene in Escherichia coli: lon is dispensable , 1985, Journal of bacteriology.

[59]  J. Broach,et al.  Properties of REP3: a cis-acting locus required for stable propagation of the Saccharomyces cerevisiae plasmid 2 microns circle , 1985, Molecular and cellular biology.

[60]  M. Uhlén,et al.  Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors. , 1985, The EMBO journal.

[61]  L. Shaw,et al.  Development of a stable reference material for prostatic acid phosphatase. , 1984, Clinical chemistry.

[62]  C. Petitclerc,et al.  Transferability studies for the AACC reference method and the IFCC method for measurement of alkaline phosphatase activity. , 1984, Clinical chemistry.

[63]  E. Gilboa,et al.  Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection , 1984, Journal of virology.

[64]  T. Maniatis,et al.  High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector , 1984, Molecular and cellular biology.

[65]  D Coit,et al.  Chemical synthesis of a gene for human epidermal growth factor urogastrone and its expression in yeast. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Y. Kikuchi.  Yeast plasmid requires a cis-acting locus and two plasmid proteins for its stable maintenance , 1983, Cell.

[67]  L. Shaw,et al.  International Federation of Clinical Chemistry, (IFCC), Scientific Committee, Analytical Section. IFCC methods for the measurement of catalytic concentration of enzymes. Part 4. IFCC method for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2.3.2.2]. , 1983, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[68]  J. Broach,et al.  The yeast plasmid 2μ circle encodes components required for its high copy propagation , 1983, Cell.

[69]  A. Kingsman,et al.  Expression in Saccharomyces cerevisiae of human interferon-alpha directed by the TRP1 5' region. , 1983, Nucleic acids research.

[70]  D. Goeddel,et al.  Expression of the human interferon–γ cDNA in yeast , 1983 .

[71]  L. J. Perry,et al.  Secretion of human interferons by yeast. , 1983, Science.

[72]  D. Williams,et al.  Cytoplasmic inclusion bodies in Escherichia coli producing biosynthetic human insulin proteins. , 1982, Science.

[73]  Gustav Ammerer,et al.  Expression of a human gene for interferon in yeast , 1981, Nature.

[74]  M. Ciriacy,et al.  A positive regulatory gene is required for accumulation of the functional messenger RNA for the glucose-repressible alcohol dehydrogenase from Saccharomyces cerevisiae. , 1981, Journal of molecular biology.

[75]  E. Sampson,et al.  Characterization and intermethod relationships of materials containing purified human pancreatic and salivary amylase. , 1981, Clinical chemistry.

[76]  H. Bergmeyer.  IFCC methods for the measurement of catalytic concentrations of enzymes: Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2)☆ , 1980 .

[77]  C. Burtis,et al.  An interlaboratory evaluation of the IFCC method for aspartate aminotransferase with use of purified enzyme materials. , 1980, Clinical chemistry.

[78]  K. Cantell,et al.  Synthesis in E. coli of a polypeptide with human leukocyte interferon activity , 1980, Nature.

[79]  P. Seeburg,et al.  Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone , 1979, Nature.

[80]  G. Siest,et al.  Relations between reported alcohol consumption and certain biological variables in an "unselected" population. , 1979, Clinical chemistry.

[81]  J. Beckwith,et al.  Use of gene fusion to study secretion of maltose-binding protein into Escherichia coli periplasm , 1979, Journal of bacteriology.

[82]  G. Fink,et al.  Transformation of yeast. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[83]  D. Zipser,et al.  Deg phenotype of Escherichia coli lon mutants , 1978, Journal of bacteriology.

[84]  A. Riggs,et al.  Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. , 1977, Science.

[85]  S. Falkow,et al.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. , 1977, Gene.

[86]  M. Ross,et al.  Human kidney gamma-glutamyl transpeptidase. Catalytic properties, subunit structure, and localization of the gamma-glutamyl binding site on the light subunit. , 1977, The Journal of biological chemistry.

[87]  A. H. Richards,et al.  Proficiency testing: purification of lactate dehydrogenase 1 and results of its use as a reference material in the New York State program. , 1977, Clinical chemistry.

[88]  Richard Axel,et al.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells , 1977, Cell.

[89]  C. Ballou,et al.  Genetic control of yeast mannan structure. Isolation and characterization of mannan mutants. , 1973, The Journal of biological chemistry.

[90]  R. Rej,et al.  An L-aspartate: 2-oxoglutarate aminotransferase reference material from human erythrocytes: preparation and characterization. , 1972, Clinical Chemistry.

[91]  J. M. Adams,et al.  On the release of the formyl group from nascent protein. , 1968, Journal of molecular biology.

[92]  S. Enfors.  Control of in vivo proteolysis in the production of recombinant proteins. , 1992, Trends in biotechnology.

[93]  J. Goergen,et al.  PRODUCTION OF HUMAN GAMMA-GLUTAMYLTRANSFERASE BY MASS CULTURES OF HUMAN HEPATOMA AND RECOMBINANT CHO CELLS , 1992 .

[94]  T Gojobori,et al.  Codon usage tabulated from the GenBank genetic sequence data. , 1991, Nucleic acids research.

[95]  M. Mclellan,et al.  Cryopreservation and the maintenance of cell lines. , 1990, Trends in biotechnology.

[96]  G. Lorimer,et al.  Chaperonin assisted polypeptide folding and assembly: implications for the production of functional proteins in bacteria. , 1990, Trends in biotechnology.

[97]  H. Pitot,et al.  Human gamma-glutamyl transpeptidase cDNA: comparison of hepatoma and kidney mRNA in the human and rat. , 1989, Gene.

[98]  T Gojobori,et al.  Codon usage tabulated from the GenBank Genetic Sequence Data. , 1988, Nucleic acids research.

[99]  K D Wilkinson,et al.  Protein ubiquitination: a regulatory post-translational modification. , 1987, Anti-cancer drug design.

[100]  A. Cigan,et al.  Sequence and structural features associated with translational initiator regions in yeast--a review. , 1987, Gene.

[101]  W. Szybalski,et al.  Control of cloned gene expression by promoter inversion in vivo: construction of improved vectors with a multiple cloning site and the Ptac promoter. , 1987, Gene.

[102]  I. Schwartz,et al.  Measurement of cat expression from growth-rate-regulated promoters employing beta-lactamase activity as an indicator of plasmid copy number. , 1987, Gene.

[103]  G. Siest,et al.  [Reference materials in clinical enzymology]. , 1986, Annales de Biologie Clinique.

[104]  A Fiechter,et al.  Growth control in microbial cultures. , 1985, Annual review of microbiology.

[105]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[106]  D. Fast,et al.  Development of a reference material for alkaline phosphatase. , 1984, Clinical chemistry.

[107]  G. Sato,et al.  Methods for preparation of media, supplements, and substrata for serum-free animal cell culture , 1984 .

[108]  D. Goeddel,et al.  Expression of the human interferon-gamma cDNA in yeast. , 1983, Nucleic acids research.

[109]  N. Katunuma,et al.  Membrane bound gamma-glutamyltranspeptidase: its structure, biosynthesis and degradation. , 1983, Advances in Enzyme Regulation.

[110]  G. Siest,et al.  Effect of chronic ethanol administration on gamma-glutamyltransferase activities in plasma and in hepatic plasma membranes of male and female rats. , 1982, Enzyme.

[111]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[112]  J. Broach.  The yeast plasmid 2 mu circle. , 1982, Cell.

[113]  M. Harder.  IFCC METHODS FOR THE MEASUREMENT OF CATALYTIC CONCENTRATION OF ENZYMES , 1980 .

[114]  R E Vanderlinde,et al.  A discussion of enzyme reference materials: applications and specifications. , 1973, Clinical chemistry.

[115]  D. Moss.  Accuracy, precision, and quality control of enzyme assays. , 1970, Journal of clinical pathology. Supplement.